HK1205514A1 - Antibacterial quinoline derivatives - Google Patents
Antibacterial quinoline derivativesInfo
- Publication number
- HK1205514A1 HK1205514A1 HK15106132.9A HK15106132A HK1205514A1 HK 1205514 A1 HK1205514 A1 HK 1205514A1 HK 15106132 A HK15106132 A HK 15106132A HK 1205514 A1 HK1205514 A1 HK 1205514A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- quinoline derivatives
- antibacterial quinoline
- antibacterial
- derivatives
- quinoline
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12165934 | 2012-04-27 | ||
PCT/EP2013/058703 WO2013160435A1 (en) | 2012-04-27 | 2013-04-26 | Antibacterial quinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205514A1 true HK1205514A1 (en) | 2015-12-18 |
Family
ID=48227271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106132.9A HK1205514A1 (en) | 2012-04-27 | 2015-06-29 | Antibacterial quinoline derivatives |
Country Status (15)
Country | Link |
---|---|
US (1) | US9133167B2 (xx) |
EP (1) | EP2841425B1 (xx) |
JP (1) | JP6153604B2 (xx) |
KR (1) | KR102110355B1 (xx) |
CN (1) | CN104254527B (xx) |
AU (1) | AU2013254674B2 (xx) |
CA (1) | CA2869718C (xx) |
DK (1) | DK2841425T3 (xx) |
EA (1) | EA035443B1 (xx) |
ES (1) | ES2576491T3 (xx) |
HK (1) | HK1205514A1 (xx) |
IN (1) | IN2014MN02364A (xx) |
MX (1) | MX355050B (xx) |
PL (1) | PL2841425T3 (xx) |
WO (1) | WO2013160435A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA038350B1 (ru) * | 2012-04-27 | 2021-08-12 | Янссен Фармацевтика Нв | Антибактериальные хинолиновые производные |
US10160726B2 (en) * | 2014-08-06 | 2018-12-25 | Novartis Ag | Quinolone derivatives as antibacterials |
EP4148053A1 (en) * | 2016-03-07 | 2023-03-15 | The Global Alliance for TB Drug Development, Inc. | Antibacterial compounds and uses thereof |
KR102574912B1 (ko) * | 2016-08-17 | 2023-09-07 | 덕산네오룩스 주식회사 | 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치 |
US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965572A (en) | 1996-10-28 | 1999-10-12 | The United States Of America As Respresented By The Secretary Of The Army | Methods for treating antibiotic-resistant infections |
US6103905A (en) | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
NZ538391A (en) | 2002-07-25 | 2005-10-28 | Janssen Pharmaceutica Nv | Quinoline derivatives and their use as mycobacterial inhibitors |
DK1711181T3 (da) | 2004-01-23 | 2010-02-01 | Janssen Pharmaceutica Nv | Quinolin-derivater og anvendelse af disse som mycobakterielle inhibitorer |
US7338949B2 (en) * | 2004-01-23 | 2008-03-04 | Janssen Pharmaceutica N.V. | Mycobacterial inhibitors |
DE602005006744D1 (de) | 2004-01-29 | 2008-06-26 | Janssen Pharmaceutica Nv | Chinolinderivate zur verwendung als inhibitoren von mycobakterien |
KR101371653B1 (ko) | 2004-05-28 | 2014-03-07 | 얀센 파마슈티카 엔.브이. | 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린유도체의 용도 |
WO2005123081A2 (en) | 2004-06-22 | 2005-12-29 | Janssen Pharmaceutica N.V. | (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia |
RU2418001C2 (ru) | 2004-09-28 | 2011-05-10 | Янссен Фармацевтика Н.В. | Домен связывания бактериальной атр-синтазы |
EE05394B1 (et) | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
CA2528849C (en) | 2005-06-08 | 2014-01-14 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
JO3270B1 (ar) | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
WO2007000434A1 (en) | 2005-06-28 | 2007-01-04 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO3077B1 (ar) | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
JO2855B1 (en) | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO2952B1 (en) | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
JO2837B1 (en) | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
JO2685B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2684B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2683B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
CA2711912A1 (en) * | 2008-01-14 | 2009-07-23 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
EA038350B1 (ru) * | 2012-04-27 | 2021-08-12 | Янссен Фармацевтика Нв | Антибактериальные хинолиновые производные |
-
2013
- 2013-04-26 PL PL13719524.4T patent/PL2841425T3/pl unknown
- 2013-04-26 KR KR1020147031040A patent/KR102110355B1/ko active IP Right Grant
- 2013-04-26 WO PCT/EP2013/058703 patent/WO2013160435A1/en active Application Filing
- 2013-04-26 IN IN2364MUN2014 patent/IN2014MN02364A/en unknown
- 2013-04-26 EA EA201491982A patent/EA035443B1/ru not_active IP Right Cessation
- 2013-04-26 MX MX2014013056A patent/MX355050B/es active IP Right Grant
- 2013-04-26 JP JP2015507549A patent/JP6153604B2/ja active Active
- 2013-04-26 DK DK13719524.4T patent/DK2841425T3/en active
- 2013-04-26 US US14/391,045 patent/US9133167B2/en active Active
- 2013-04-26 ES ES13719524.4T patent/ES2576491T3/es active Active
- 2013-04-26 AU AU2013254674A patent/AU2013254674B2/en active Active
- 2013-04-26 CA CA2869718A patent/CA2869718C/en active Active
- 2013-04-26 CN CN201380021790.5A patent/CN104254527B/zh active Active
- 2013-04-26 EP EP13719524.4A patent/EP2841425B1/en active Active
-
2015
- 2015-06-29 HK HK15106132.9A patent/HK1205514A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN104254527A (zh) | 2014-12-31 |
MX355050B (es) | 2018-04-02 |
EP2841425B1 (en) | 2016-03-23 |
EP2841425A1 (en) | 2015-03-04 |
DK2841425T3 (en) | 2016-06-27 |
WO2013160435A1 (en) | 2013-10-31 |
MX2014013056A (es) | 2014-12-10 |
CA2869718C (en) | 2021-05-11 |
JP2015518003A (ja) | 2015-06-25 |
CA2869718A1 (en) | 2013-10-31 |
IN2014MN02364A (xx) | 2015-08-14 |
ES2576491T3 (es) | 2016-07-07 |
AU2013254674A1 (en) | 2014-10-16 |
KR20150013156A (ko) | 2015-02-04 |
EA201491982A1 (ru) | 2015-02-27 |
US9133167B2 (en) | 2015-09-15 |
US20150065502A1 (en) | 2015-03-05 |
CN104254527B (zh) | 2017-05-31 |
AU2013254674B2 (en) | 2017-02-02 |
PL2841425T3 (pl) | 2016-10-31 |
JP6153604B2 (ja) | 2017-06-28 |
KR102110355B1 (ko) | 2020-05-14 |
EA035443B1 (ru) | 2020-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200040I1 (hu) | Benzimidazol-prolin származékok | |
HK1211022A1 (en) | Novel quinolone derivatives | |
HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
HK1206031A1 (en) | Antibacterial compounds | |
ZA201502175B (en) | Oxazolidin-2-one-pyrimidine derivatives | |
HK1205514A1 (en) | Antibacterial quinoline derivatives | |
HK1200824A1 (en) | Substituted phenylazole derivative | |
EP2882430A4 (en) | ANTIBACTERIAL INHIBITORS | |
GB201206384D0 (en) | Antibacterial drug derivatives | |
ZA201501640B (en) | Tricyclic tetrahydroquinoline antibacterial agents | |
HK1201520A1 (en) | Antibacterial quinoline derivatives | |
HK1210954A1 (en) | Antibacterial compounds | |
IL239207A0 (en) | Antibacterial compounds | |
GB201206385D0 (en) | Antibacterial drug derivatives | |
GB201206383D0 (en) | Antibacterial drug derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230420 |